Edgewise Therapeutics, Inc. EWTX Business Segments — Interest Income Expense Nonoperating Net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Edgewise Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.
The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edgewise Therapeutics, Inc.'s business segments — interest income expense nonoperating net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edgewise Therapeutics, Inc.'s business segments — interest income expense nonoperating net?
- Edgewise Therapeutics, Inc. (EWTX) reported business segments — interest income expense nonoperating net of $5.1M in Q1 2026.
- How has Edgewise Therapeutics, Inc.'s business segments — interest income expense nonoperating net changed year-over-year?
- Edgewise Therapeutics, Inc.'s business segments — interest income expense nonoperating net decreased by 1.1% year-over-year, from $5.16M to $5.1M.
- What does business segments — interest income expense nonoperating net mean?
- Captures the net balance of interest earned on cash and investments versus interest paid on debt obligations. This metric reflects the company's treasury management performance and its reliance on external financing. It is a critical component of non-operating financial health for companies with significant cash reserves.